BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 33856167)

  • 1. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
    Yew KS; Kamps-Schmitt KA; Borge R
    Am Fam Physician; 2021 Apr; 103(8):481-492. PubMed ID: 33856167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.
    Peterson B; Coda A; Pacey V; Hawke F
    J Foot Ankle Res; 2018; 11():59. PubMed ID: 30455744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary approach to joint hypermobility and related disorders.
    Castori M; Hakim A
    Curr Opin Pediatr; 2017 Dec; 29(6):640-649. PubMed ID: 28906340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
    Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
    Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective health complaints and illness perception amongst adults with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-HypermobilityType - a cross-sectional study.
    Hope L; Juul-Kristensen B; Løvaas H; Løvvik C; Maeland S
    Disabil Rehabil; 2019 Feb; 41(3):333-340. PubMed ID: 29041819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders.
    Colombi M; Dordoni C; Chiarelli N; Ritelli M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):6-22. PubMed ID: 25821090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type.
    Krahe AM; Adams RD; Nicholson LL
    Disabil Rehabil; 2018 Aug; 40(17):1989-1996. PubMed ID: 28482708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome.
    Forghani I
    Balkan Med J; 2019 Jan; 36(1):12-16. PubMed ID: 30063214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [[Joint hypermobility: when to evoke Ehlers-Danlos syndrome]?].
    P Germain D
    Rev Prat; 2016 Apr; 66(4):423-429. PubMed ID: 30512708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome.
    Roma M; Marden CL; De Wandele I; Francomano CA; Rowe PC
    Auton Neurosci; 2018 Dec; 215():89-96. PubMed ID: 29519641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
    Gensemer C; Burks R; Kautz S; Judge DP; Lavallee M; Norris RA
    Dev Dyn; 2021 Mar; 250(3):318-344. PubMed ID: 32629534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic Joint Hypermobility: The Hypermobile Type of Ehlers-Danlos Syndrome and the Hypermobility Spectrum Disorders.
    Tinkle BT; Levy HP
    Med Clin North Am; 2019 Nov; 103(6):1021-1033. PubMed ID: 31582002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
    Teran-Wodzinski P; Kumar A
    Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Underrecognized Conditions of Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders in Women.
    Robbins K
    Nurs Womens Health; 2022 Jun; 26(3):174-183. PubMed ID: 35533735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Management of Shoulder and Knee Instability in Patients with Ehlers-Danlos Syndrome: Joint Hypermobility Syndrome.
    Homere A; Bolia IK; Juhan T; Weber AE; Hatch GF
    Clin Orthop Surg; 2020 Sep; 12(3):279-285. PubMed ID: 32904109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
    Micale L; Fusco C; Castori M
    Adv Exp Med Biol; 2021; 1348():207-233. PubMed ID: 34807421
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.